{
  "simulation_id": "sim_20250503_164208",
  "config": {
    "use_team_leadership": false,
    "use_closed_loop_comm": false,
    "use_mutual_monitoring": false,
    "use_shared_mental_model": false,
    "use_team_orientation": false,
    "use_mutual_trust": true,
    "mutual_trust_factor": 0.9,
    "use_recruitment": true,
    "recruitment_method": "adaptive",
    "recruitment_pool": "general",
    "random_leader": false,
    "task": "Autoimmune Encephalitis Diagnosis"
  },
  "exchanges": [
    {
      "type": "collaborative_discussion",
      "communication": "standard",
      "sender": "Neurologist",
      "message": "**Single letter selection with rationale: B**\n\n### Final Answer and Rationale:\nAfter reviewing the analyses provided by all team members, including the Immunologist, Neuroradiologist, Rheumatologist, and Neuropsychiatrist, as well as my own expertise as a Neurologist, the most likely autoantibody associated with this clinical presentation is **Anti-LGI1 antibodies**.\n\n#### Key Points Supporting the Answer:\n1. **Clinical Presentation**:\n   - Subacute onset of memory deficits, confusion, and behavioral changes is highly consistent with **limbic encephalitis**, a hallmark of anti-LGI1 encephalitis.\n   - While seizures (e.g., faciobrachial dystonic seizures) are commonly associated with anti-LGI1 encephalitis, their absence does not exclude the diagnosis.\n\n2. **MRI Findings**:\n   - Bilateral medial temporal lobe hyperintensities are a classic imaging feature of **anti-LGI1 encephalitis**. Other autoimmune encephalitides, such as those associated with anti-NMDA receptor or anti-GABA-B receptor antibodies, do not typically present with this specific MRI pattern.\n\n3. **CSF and EEG Findings**:\n   - Mild lymphocytic pleocytosis in the CSF and focal slowing in the temporal regions on EEG are supportive of **limbic encephalitis** and are frequently seen in anti-LGI1 encephalitis.\n\n4. **Demographics**:\n   - Anti-LGI1 encephalitis typically affects middle-aged individuals but can also occur in younger adults, as in this case. It is not commonly associated with malignancies, unlike anti-GABA-B or anti-AMPA receptor encephalitis.\n\n5. **Comparison with Other Options**:\n   - **Anti-NMDA receptor antibodies**: Less likely due to the absence of characteristic features such as movement disorders, autonomic instability, or psychiatric symptoms, and the MRI findings are atypical.\n   - **Anti-GABA-B receptor antibodies**: Less likely due to the patient's age and the lack of paraneoplastic features or severe seizures.\n   - **Anti-AMPA receptor antibodies**: Unlikely due to its rarity, typical association with malignancies, and demographic mismatch.\n\nGiven the alignment of the clinical, imaging, and laboratory findings with **anti-LGI1 encephalitis**, **Option B** is the correct answer.\n\n**Final Answer: B. Anti-LGI1 antibodies**"
    },
    {
      "type": "collaborative_discussion",
      "communication": "standard",
      "sender": "Immunologist",
      "message": "**Final Answer: B**\n\n**Rationale:**  \nIntegrating my analysis with the perspectives of my teammates, the clinical presentation of subacute onset memory deficits, confusion, and behavioral changes, along with bilateral medial temporal lobe hyperintensities on MRI, mild lymphocytic pleocytosis in the CSF, and focal temporal slowing on EEG, is most consistent with **anti-LGI1 encephalitis**. This condition is a well-recognized cause of autoimmune limbic encephalitis, particularly in middle-aged individuals. The imaging findings are characteristic, and the absence of malignancy further supports this diagnosis over other options such as anti-GABA-B receptor or anti-AMPA receptor antibodies. Anti-NMDA receptor encephalitis, while common, typically presents with additional features not seen in this case, such as movement disorders or autonomic instability."
    },
    {
      "type": "collaborative_discussion",
      "communication": "standard",
      "sender": "Neuroradiologist",
      "message": "**Final Answer: B. Anti-LGI1 antibodies**\n\n### Rationale:\nAfter considering my initial analysis and the insights provided by my teammates (Neurologist, Immunologist, Rheumatologist, and Neuropsychiatrist), the consensus strongly supports **anti-LGI1 antibodies** as the most likely cause of this patient's presentation. \n\nThe clinical findings of **subacute memory deficits, confusion, and behavioral changes**, coupled with **bilateral medial temporal lobe hyperintensities on MRI**, **mild lymphocytic pleocytosis in CSF**, and **focal temporal slowing on EEG**, align most closely with **anti-LGI1 encephalitis**, a common form of autoimmune limbic encephalitis. This condition is well-known for its characteristic MRI findings and clinical presentation, and it fits the patient's age and demographic profile.\n\nOther options (anti-NMDA receptor, anti-GABA-B receptor, and anti-AMPA receptor antibodies) are less likely due to discrepancies in typical imaging findings, demographic associations, or the absence of paraneoplastic features in this case. \n\nThus, the most accurate diagnosis is **anti-LGI1 encephalitis**, making **B** the correct answer."
    },
    {
      "type": "collaborative_discussion",
      "communication": "standard",
      "sender": "Rheumatologist",
      "message": "**Final Answer: B**\n\n**Rationale:** Integrating the analyses from all team members, the clinical presentation of subacute memory deficits, confusion, and behavioral changes, along with MRI findings of bilateral medial temporal lobe hyperintensities, CSF lymphocytic pleocytosis, and EEG focal slowing in the temporal regions, is most consistent with **limbic encephalitis** caused by **anti-LGI1 antibodies**. Anti-LGI1 encephalitis is strongly associated with the described constellation of findings and is the most likely diagnosis given the patient's age and clinical context. Other options, such as anti-NMDA receptor, anti-GABA-B receptor, and anti-AMPA receptor antibodies, are less likely based on the specific imaging, demographic, and clinical features."
    },
    {
      "type": "collaborative_discussion",
      "communication": "standard",
      "sender": "Neuropsychiatrist",
      "message": "**Final Answer: B. Anti-LGI1 antibodies**\n\n### Integrated Rationale:\nAfter synthesizing the analyses from all team members, including my own, the most likely autoantibody associated with this clinical presentation is **anti-LGI1 antibodies**. The reasoning is as follows:\n\n1. **Clinical Presentation**: The subacute onset of memory deficits, confusion, and behavioral changes is classic for limbic encephalitis. Anti-LGI1 encephalitis is the most common autoimmune cause of limbic encephalitis, particularly in middle-aged adults.\n\n2. **MRI Findings**: Bilateral medial temporal lobe hyperintensities are highly characteristic of anti-LGI1 encephalitis and strongly point to this diagnosis.\n\n3. **CSF and EEG Findings**: Mild lymphocytic pleocytosis in the CSF and focal slowing in the temporal regions on EEG are consistent with the inflammatory and localized nature of limbic encephalitis caused by anti-LGI1 antibodies.\n\n4. **Exclusion of Other Options**:\n   - **Anti-NMDA receptor antibodies**: While this condition can present with psychiatric symptoms and memory deficits, the MRI findings of bilateral medial temporal lobe hyperintensities are atypical. Additionally, the absence of hallmark features like movement disorders or autonomic instability makes this less likely.\n   - **Anti-GABA-B receptor antibodies**: Although it can cause limbic encephalitis, it is more commonly associated with older individuals and paraneoplastic syndromes, which are not mentioned in this case.\n   - **Anti-AMPA receptor antibodies**: This condition is rare, often associated with malignancies, and typically occurs in older patients. The patient's age and lack of malignancy history make this diagnosis unlikely.\n\nGiven the combination of clinical, radiological, and laboratory findings, **anti-LGI1 antibodies** are the most likely cause in this case."
    }
  ],
  "decision_results": {
    "majority_voting": {
      "method": "majority_voting",
      "winning_option": null,
      "vote_counts": {},
      "total_votes": 5,
      "confidence": 0
    },
    "weighted_voting": {
      "method": "weighted_voting",
      "winning_option": null,
      "vote_counts": {},
      "weighted_votes": {},
      "total_votes": 0,
      "confidence": 0
    },
    "borda_count": {
      "method": "borda_count",
      "winning_option": null,
      "borda_scores": {
        "A": 0,
        "B": 0,
        "C": 0,
        "D": 0
      },
      "total_possible_score": 0.0,
      "confidence": 0
    }
  },
  "teamwork_metrics": {}
}